TSVT: 2seventy bio, Inc. Stock

by  •  • Comments Off on TSVT: 2seventy bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 220.12
Enterprise Value ($M) 145.17
Book Value ($M) 306.42
Book Value / Share 5.97
Price / Book 0.72
NCAV ($M) -72.36
NCAV / Share -1.41
Price / NCAV -3.04

Profitability (mra)
Return on Invested Capital (ROIC) -0.39
Return on Assets (ROA) -0.29
Return on Equity (ROE) -0.70

Liquidity (mrq)
Quick Ratio 3.98
Current Ratio 3.98

Balance Sheet (mrq) ($M)
Current Assets 237.76
Assets 565.43
Liabilities 310.13
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 100.39
Operating Income -216.70
Net Income -217.57

Cash Flow Statement (mra) ($M)
Cash From Operations -166.86
Cash from Investing 43.86
Cash from Financing 127.39

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Citadel Advisors Llc 0.30
02-14 13G/A Baker Bros. Advisors Lp 4.99
02-13 13G/A Vanguard Group Inc 7.87 65.78
02-12 13G Morgan Stanley 9.40
02-08 13G Goldman Sachs Group Inc 8.80
02-01 13G/A Millennium Management Llc 4.70
01-26 13G/A BlackRock Inc. 7.70 30.10
01-23 13G/A State Street Corp 1.93 -8.56
11-09 13G/A Wellington Management Group Llp 1.59
09-06 13G Kynam Capital Management, LP 11.70

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-12-01 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A AMENDMENT NO. 1
2023-12-01 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A AMENDMENT NO. 1
2023-12-01 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A AMENDMENT NO. 1
2023-12-01 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A AMENDMENT NO. 1
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 66,861 294,873 22.67
2024-04-25 1,334,682 3,657,252 36.49
2024-04-24 103,631 115,452 89.76
2024-04-23 42,450 98,817 42.96
2024-04-22 68,597 117,370 58.45

(click for more detail)

Similar Companies
TNYA – Tenaya Therapeutics, Inc. TRML – Tourmaline Bio, Inc.
TSHA – Taysha Gene Therapies, Inc. TWST – Twist Bioscience Corporation
TXMD – TherapeuticsMD, Inc.


Financial data and stock pages provided by
Fintel.io